PPARA antibody (AA 179-228)
Quick Overview for PPARA antibody (AA 179-228) (ABIN6741860)
Target
See all PPARA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 179-228
-
Specificity
- Human PPARA / PPAR
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%) Bovine, Goat (93%) Mouse, Rat, Horse, Pig (86%) Dog (80%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa179-228 of human Piezo (Q07869, NP_005027). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey (100%), Goat, Hamster, Bovine (93%), Galago (92%), Mouse, Rat, Horse, Pig, Opossum (86%), Marmoset (85%), Panda, Dog, Platypus (80%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:62500. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- PPARA (Peroxisome Proliferator-Activated Receptor alpha (PPARA))
-
Alternative Name
- PPAR alpha
-
Background
-
Name/Gene ID: PPARA
Subfamily: NR1 Thyroid hormone-like
Family: NHR
Synonyms: PPARA, PPAR Alpha, PPARalpha, PPAR-alpha, NR1C1, HPPAR, PPAR -
Gene ID
- 5465
-
NCBI Accession
- NP_005027
-
UniProt
- Q07869
-
Pathways
- Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha, Regulation of Carbohydrate Metabolic Process, Hepatitis C
Target
-